Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study

Luis C. Bertot; Eduardo Vilar Gomez; Vincent W. Wong; Marlen Castellanos Fernandez; Rocio Aller; Mohammed Eslam; Jacob George; Manuel Romero-Gomez; Leon A. Adams

Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study

Luis C. Bertot, Eduardo Vilar Gomez, Vincent W. Wong, Marlen Castellanos Fernandez, Rocio Aller, Mohammed Eslam, Jacob George, Manuel Romero-Gomez, Leon A. Adams

UWA Medical School

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	1119A-1119A
Number of pages	1
Journal	Hepatology
Volume	66
Publication status	Published - Oct 2017
Event	68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting - Washington, United States Duration: 20 Oct 2017 → 24 Oct 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Bertot, L. C., Gomez, E. V., Wong, V. W., Fernandez, M. C., Aller, R., Eslam, M., George, J., Romero-Gomez, M., & Adams, L. A. (2017). Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study. Hepatology, 66, 1119A-1119A.

@article{915a9226208945fa838efa7ebf2157b1,

title = "Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study",

author = "Bertot, {Luis C.} and Gomez, {Eduardo Vilar} and Wong, {Vincent W.} and Fernandez, {Marlen Castellanos} and Rocio Aller and Mohammed Eslam and Jacob George and Manuel Romero-Gomez and Adams, {Leon A.}",

year = "2017",

month = oct,

language = "English",

volume = "66",

pages = "1119A--1119A",

journal = "Hepatology",

issn = "0270-9139",

publisher = "John Wiley & Sons",

note = "68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting ; Conference date: 20-10-2017 Through 24-10-2017",

}

Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study. / Bertot, Luis C.; Gomez, Eduardo Vilar; Wong, Vincent W. et al.
In: Hepatology, Vol. 66, 10.2017, p. 1119A-1119A.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study

AU - Bertot, Luis C.

AU - Gomez, Eduardo Vilar

AU - Wong, Vincent W.

AU - Fernandez, Marlen Castellanos

AU - Aller, Rocio

AU - Eslam, Mohammed

AU - George, Jacob

AU - Romero-Gomez, Manuel

AU - Adams, Leon A.

PY - 2017/10

Y1 - 2017/10

M3 - Abstract/Meeting Abstract

SN - 0270-9139

VL - 66

SP - 1119A-1119A

JO - Hepatology

JF - Hepatology

T2 - 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting

Y2 - 20 October 2017 through 24 October 2017

ER -